Corbevax vaccine, developed by Biological E, is a RBD protein sub-unit vaccine against novel coronavirus. Its development was supported by the Department of Biotechnology and its public sector undertaking ? Biotechnology Industry Research Assistance Council (BIRAC). It received financial assistance from Mission COVID Suraskha and COVID-19 Research Consortia through National Biopharma Mission.
The indigenously-made covid vaccine candidate recently received the approval from the Drugs Controller General of India (DCGI) to conduct phase 2 and phase 3 trials for children between 5 and 18 years of age. The Indian government is set to receive 30 crore doses of this vaccine by the end of this year.
No comments yet.